KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCA Healthcare (HCA) Cash & Current Investments (2016 - 2026)

HCA Healthcare (HCA) has disclosed Cash & Current Investments for 17 consecutive years, with $940.0 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Current Investments fell 11.32% year-over-year to $940.0 million; the TTM value through Mar 2026 reached $940.0 million, down 11.32%, while the annual FY2025 figure was $1.0 billion, 46.2% down from the prior year.
  • Cash & Current Investments hit $940.0 million in Q1 2026 for HCA Healthcare, down from $1.0 billion in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $2.9 billion in Q3 2024 and bottomed at $493.0 million in Q2 2022.
  • Average Cash & Current Investments over 5 years is $1.1 billion, with a median of $939.0 million recorded in 2025.
  • Year-over-year, Cash & Current Investments surged 224.13% in 2024 and then plummeted 65.48% in 2025.
  • HCA Healthcare's Cash & Current Investments stood at $908.0 million in 2022, then increased by 2.97% to $935.0 million in 2023, then skyrocketed by 106.74% to $1.9 billion in 2024, then crashed by 46.2% to $1.0 billion in 2025, then fell by 9.62% to $940.0 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $940.0 million, $1.0 billion, and $997.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.